We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.53B
AUM Growth
+$224M
Cap. Flow
+$172M
Cap. Flow %
11.23%
Top 10 Hldgs %
40.36%
Holding
96
New
31
Increased
23
Reduced
14
Closed
23

Top Sells

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$51.6M
2
UTHR icon
United Therapeutics
UTHR
+$43.6M
3
CAKE icon
Cheesecake Factory
CAKE
+$37.1M
4
POST icon
Post Holdings
POST
+$29.7M
5
ASRT
Assertio
ASRT
+$28.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.79%
2 Consumer Discretionary 23.39%
3 Consumer Staples 8.62%
4 Communication Services 0.74%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$195M 12.75%
720,000
+160,000
+29% +$43.2M
AVTX icon
2
Avalo Therapeutics
AVTX
$940M
$71.2M 4.65%
5,699
+126
+2% +$1.5M
EPC icon
3
Edgewell Personal Care
EPC
$1.34B
$55.1M 3.6%
+1,092,000
New +$50.2M
MNK
4
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$44.8M 2.92%
+2,400,000
New +$38.2M
REGN icon
5
Regeneron Pharmaceuticals
REGN
$71.2B
$44.2M 2.88%
128,000
+20,000
+19% +$6.26M
VNDA icon
6
Vanda Pharmaceuticals
VNDA
$328M
$42.4M 2.77%
2,224,000
-376,000
-14% -$6.29M
HOG icon
7
Harley-Davidson
HOG
$2.82B
$42.1M 2.75%
1,000,000
+272,000
+37% +$11.5M
CPB icon
8
CALL
Campbell Soup
CPB
$6.75B
$41.4M 2.7%
+1,020,000
New +$39.7M
SGI
9
Somnigroup International
SGI
$15.8B
$41.1M 2.69%
3,424,000
+704,000
+26% +$8.3M
AMAG
10
DELISTED
AMAG Pharmaceuticals
AMAG
$40.6M 2.65%
2,080,000
+176,000
+9% +$3.89M
PZZA icon
11
CALL
Papa John's
PZZA
$1.11B
$38M 2.48%
750,000
+150,000
+25% +$8.42M
SJM icon
12
J.M. Smucker
SJM
$12.2B
$34.8M 2.27%
+324,000
New +$36.4M
PRKS icon
13
United Parks & Resorts
PRKS
$2.22B
$34.4M 2.25%
1,576,000
-424,000
-21% -$7.52M
DESP
14
DELISTED
Despegar.com
DESP
$33.4M 2.18%
1,592,000
+984,000
+162% +$25.3M
CVS icon
15
CVS Health
CVS
$136B
$32.2M 2.1%
500,000
+8,000
+2% +$527K
PLYA
16
DELISTED
Playa Hotels & Resorts
PLYA
$31.7M 2.07%
2,936,000
ATRS
17
DELISTED
Antares Pharma, Inc.
ATRS
$31.1M 2.03%
12,050,000
-510,000
-4% -$1.27M
INCY icon
18
Incyte
INCY
$23.3B
$28.7M 1.87%
+428,000
New +$29.3M
CAKE icon
19
CALL
Cheesecake Factory
CAKE
$4.14B
$28.6M 1.87%
+520,000
New +$27.5M
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
$28.4M 1.85%
624,000
+156,000
+33% +$7.59M
BLUE
21
DELISTED
bluebird bio
BLUE
$28.3M 1.84%
13,896
+9,264
+200% +$21.1M
HBI
22
DELISTED
Hanesbrands
HBI
$28.2M 1.84%
1,280,000
-720,000
-36% -$13.6M
GAP
23
The Gap Inc
GAP
$7.38B
$27.9M 1.82%
860,000
+220,000
+34% +$6.77M
CPRI icon
24
Capri Holdings
CPRI
$1.94B
$27.8M 1.82%
418,000
+118,000
+39% +$7.71M
FRPT icon
25
CALL
Freshpet
FRPT
$2.8B
$27.4M 1.79%
+1,000,000
New +$21.4M

Similar funds

Armistice Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Armistice Capital held 96 positions worth $1.53B, up 17% from $1.31B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Armistice Capital deployed $172M of net new capital in Q2 2018, opening 31 new positions and adding to 23 existing holdings. Its largest new stake was Edgewell Personal Care: 1,092,000 shares worth $55.1M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Assertio, an estimated $28.4M trimmed.

  • Armistice Capital's largest Q2 2018 buy was Edgewell Personal Care: 1,092,000 shares worth $55.1M.
  • Armistice Capital added most to Despegar.com in Q2 2018, an estimated $25.3M increase.
  • Armistice Capital's biggest Q2 2018 reduction was Assertio, cutting an estimated $28.4M.
  • Armistice Capital fully exited Freshpet in Q2 2018, selling an estimated $51.6M.
  • Armistice Capital's ten largest holdings make up 40% of its $1.53B portfolio in Q2 2018.
  • Armistice Capital opened 31 new positions and closed 23 in Q2 2018.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $1.53B.

Based on Armistice Capital's 13F filing for Q2 2018, filed 14 Aug 2018.